If you have been waiting on a clear conversation about whether peptide therapy fits your goals, this is a good time to have it
Want access to multiple medication options: If you and your clinician want the flexibility to choose from branded GLP-1 injectables, oral options, non-GLP-1 medications, and compounded alternatives under one clinical umbrella, Found Health describes a wide range of medication options within its program
DSIP is research-use only
observed a significant increase in pro-inflammatory cytokines alongside a decrease in serotonin levels in diabetic rats, suggesting that IDO activation may contribute to depressive-like behaviors
Presented for research literature review only Vaish S et al
We explored this further by depleting cells of both -arrestin isoforms to better represent the loss of recruitment of both -arrestins seen with exendin-phe1